hydroxychloroquin
hcq
antimalari
drug
also
use
treat
autoimmun
diseas
antivir
activ
demonstr
restrict
hiv
infect
vitro
howev
clinic
implic
remain
controversi
infect
dengu
viru
denv
global
public
health
problem
lack
antivir
drug
denv
evalu
antidenv
potenti
treatment
hcq
immunofluoresc
assay
demonstr
hcq
could
inhibit
denv
serotyp
infect
vitro
rtqpcr
analysi
hcqtreat
cell
show
induc
express
interferon
ifn
relat
antivir
protein
certain
inflammatori
cytokin
mechanist
studi
suggest
hcq
activ
innat
immun
signal
pathway
ifnb
nfkb
knock
mitochondri
antivir
signal
protein
mav
inhibit
tank
bind
kinas
inhibitorkb
kinas
e
ikk
block
type
ifn
receptor
reduc
effici
hcq
infect
furthermor
hcq
significantli
induc
cellular
product
reactiv
oxygen
speci
ro
involv
host
defens
system
suppress
ro
product
attenu
innat
immun
activ
effect
hcq
summari
hcq
trigger
host
defens
machineri
induc
rosand
mavsmedi
innat
immun
activ
denv
infect
may
candid
drug
denv
infect
f
lavivirus
includ
envelop
rna
virus
caus
seriou
diseas
human
sever
member
mosquitoborn
flavivirus
dengu
viru
serotyp
yellow
fever
viru
yfv
west
nile
viru
wnv
japanes
enceph
viru
jev
highli
pathogen
human
infect
becom
major
intern
health
problem
seligman
gould
mosquito
transmit
denv
human
main
caus
dengu
diseas
global
million
peopl
infect
per
year
worldwid
guzman
other
denvinfect
peopl
show
typic
syndrom
selflimit
febril
dengu
fever
dengu
hemorrhag
fever
dhf
lifethreaten
dengu
shock
syndrom
dss
like
occur
second
denv
infect
kyle
harri
martina
other
recent
case
surveil
reveal
particular
older
adult
increas
risk
dhfdss
death
lin
other
support
treatment
specif
therapi
vaccin
avail
guzman
other
hydroxychloroquin
hcq
chloroquin
safe
welltoler
antimalari
drug
modul
inflamm
also
improv
surviv
reduc
diseas
activ
autoimmun
diseas
system
lupu
erythematosu
rheumatoid
arthriti
syndrom
lee
other
sever
possibl
mechan
action
hcq
chloroquin
reveal
vitro
vivo
studi
includ
suppress
autoantigen
present
reduc
prostaglandin
synthesi
antiprolif
effect
photoprotect
decreas
metalloproteinas
activ
leukocyt
activ
lee
other
benzvi
other
hcq
chloroquin
cellular
autophagi
modul
interfer
phdepend
step
endosomemedi
viral
entri
late
stage
replic
envelop
virus
retrovirus
flavivirus
coronavirus
savarino
other
vincent
other
effect
hcq
chloroquin
demonstr
combin
antiretrovir
drug
zidovudin
hydroxyurea
didanosin
vitro
patient
savarino
other
paton
aboulhab
howev
hivinfect
patient
receiv
hcq
antiretrovir
therapi
show
increas
viral
replic
paton
other
hcq
chloroquin
report
interfer
flaviviru
infect
jev
intern
yfv
replic
denv
matur
brandriss
schlesing
randolph
other
zhu
other
howev
random
control
trial
chloroquin
fail
reduc
viremia
patient
dengu
diseas
tricou
other
despit
known
antivir
mechan
antimalari
drug
signal
pathway
remain
explor
innat
immun
fast
respons
type
interferon
ifn
inflammatori
cytokin
secret
trigger
nucleic
acid
viru
replic
product
tolllik
receptor
tlr
signal
kumar
other
viru
infect
doublestrand
rna
detect
group
cellular
sensor
melanoma
differentiationassoci
protein
retino
acidinduc
gene
rigi
signal
transfer
mitochondri
antivir
signal
protein
mav
tank
bind
kinas
ikk
activ
ifn
regulatori
factor
nfkb
thu
lead
express
type
ifn
variou
cytokin
kumar
other
cytokin
inhibit
viru
replic
infect
cell
regul
induct
adapt
immun
swift
erad
virus
autophagi
describ
regulatori
mechan
innat
adapt
immun
deret
levin
levin
other
pharmacolog
studi
indic
suppress
autophagi
inhibitor
chloroquin
bafilomycin
baf
activ
innat
immun
chen
studi
investig
effici
multipurpos
drug
hcq
denv
infect
abil
activ
host
defens
machineri
use
local
taiwanes
strain
genbank
access
isol
patient
dengu
fever
isol
patient
dhf
strain
kindli
provid
j
gubler
lin
other
virus
propag
mosquito
cell
line
atcc
grown
rpmi
medium
contain
fetal
bovin
serum
fb
human
lung
epitheli
carcinoma
cell
atcc
hepatoma
cell
bcrc
human
fetal
skin
normal
fibroblast
bcrc
mous
macrophag
bcrc
cell
atcc
cultur
dmem
supplement
fetal
bovin
serum
fb
invitrogen
reagent
hcq
sigmaaldrich
baf
calbiochem
recombin
human
ifna
prospec
use
inhibitor
invivogen
amlexanox
sigmaaldrich
reilli
other
reactiv
oxygen
speci
ro
inhibitor
ntertbutyl
phenylnitron
pbn
sigmaaldrich
fidanboylu
other
use
determin
viru
titer
cultur
medium
cell
harvest
plaqueform
assay
variou
viru
dilut
ad
confluent
cell
bcrc
incub
h
adsorpt
cell
wash
overlaid
agaros
seaplaqu
fmc
bioproduct
contain
rpmi
fb
day
fix
formaldehyd
stain
crystal
violet
cell
assay
bromid
mtt
roch
mgml
h
cell
supernat
replac
dmso
complet
resolv
purpl
formazon
crystal
spectrophotometr
absorb
sampl
measur
use
micropl
reader
antho
net
absorb
od
indic
enzymat
activ
mitochondria
cell
viabil
trizol
reagent
invitrogen
use
total
rna
extract
cdna
synthes
mg
total
rna
use
superscript
iii
revers
transcriptas
invitrogen
qpcr
amplif
involv
ng
cdna
ml
sybr
green
pcr
master
mix
appli
biosystem
mm
primer
abi
stepon
plu
realtim
pcr
system
appli
biosystem
transcript
level
normal
hypoxanthin
phosphoribosyltransferas
primer
sequenc
gene
detect
supplementari
tabl
supplementari
data
avail
onlin
wwwliebertpubcomjir
turbofect
transfect
reagent
thermo
scientif
use
transient
transfect
follow
manufactur
protocol
cell
cultur
plate
transfect
nfkb
isr
ifnbluc
report
plasmid
chang
other
prltk
promega
encod
renilla
luciferas
herp
simplex
viru
thymidin
kinas
promot
intern
control
case
use
yu
other
cell
lysat
collect
dualluciferas
assay
promega
firefli
luciferas
activ
normal
rel
renilla
luciferas
cell
fix
paraformaldehyd
min
permeabil
triton
min
wash
phosphatebuff
salin
pb
cell
block
skim
milk
pb
detect
incub
monoclon
antibodi
dilut
yaohong
biotechnolog
chang
other
plu
alexa
goat
antimous
igg
antibodi
invitrogen
fluoresc
signal
observ
fluoresc
microscopi
zeiss
observ
inhibit
concentr
ic
hcq
cell
estim
immunofluoresc
intens
measur
use
micropl
reader
fluroskan
ascent
fl
thermo
scientif
anti
antibodi
dilut
yaohong
biotechnolog
use
antibodydepend
enhanc
ade
infect
cell
nfkb
nuclear
transloc
assay
describ
previous
chang
other
nfkb
locat
detect
incub
primari
antibodi
antinfkb
santa
cruz
biotechnolog
respect
alex
antirabbit
igg
antibodi
invitrogen
nuclei
stain
dapi
cell
lyze
ripa
buffer
mm
nacl
sodium
deoxychol
sd
mm
trishcl
ph
contain
proteas
inhibitor
phosphotas
inhibitor
cocktail
roch
harvest
extract
separ
sodium
dodecyl
sulfatepolyacrylamid
gel
electrophoresi
transfer
polyvinyliden
fluorid
membran
incub
primari
antibodi
horseradish
peroxidaseconjug
secondari
antibodi
jackson
immunoresearch
laboratori
visual
enhanc
chemiluminesc
thermo
scientif
imag
acquir
use
digit
imag
system
biospectrum
imag
system
uvp
follow
primari
antibodi
use
antiphosphocjun
anticjun
antimav
antiikba
cell
signal
epitom
antinfkb
santa
cruz
biotechnolog
invitrogen
endoplasm
reticulum
er
stress
measur
immunoblot
use
erstress
antibodi
kit
cell
signal
includ
antibodi
immunoglobulin
heavi
chainbind
proteinglucoseregul
protein
molecular
calnexin
endoplasm
inositolrequir
protein
c
ebp
homolog
protein
chop
pkrlike
er
protein
kinas
perk
protein
disulfid
isomeras
pdi
cell
transfect
mav
knockdown
sirna
simav
neg
control
sirna
sinc
pmol
dharmacon
thermo
scientif
use
dharmafect
thermo
scientif
h
treat
hcq
h
mav
knockdown
effici
analyz
immunoblot
antimav
antibodi
cell
shmav
control
shlacz
stabl
express
previous
establish
yu
other
block
type
ifn
receptor
signal
cell
incub
type
ifn
receptor
neutral
monoclon
antibodi
millipor
dilut
h
hcq
treatment
viru
infect
cellular
ro
determin
dichlorodihydrofluorescein
diacet
dcfhda
assay
sigmaaldrich
cell
wash
pb
mm
dcfhda
ad
min
dye
discard
cell
wash
pb
dcf
fluoresc
observ
fluoresc
microscop
quantifi
use
micropl
reader
fluroskan
ascent
fl
thermo
scientif
dcf
excit
emiss
wavelength
nm
nm
respect
quantit
data
present
mean
sd
student
test
use
determin
signific
treatment
group
p
consid
statist
signific
evalu
use
hcq
infect
immunofluoresc
assay
ifa
antibodi
lung
carcinoma
cell
murin
hepatocellular
carcinoma
cell
normal
human
fibroblast
cell
hcq
dosedepend
reduc
infect
fig
inhibit
concentr
ic
hcq
infect
estim
mm
cell
mm
cell
mm
cell
plaqu
assay
indic
mm
hcq
decreas
titer
cell
fig
cell
viabil
could
factor
viru
replic
monitor
cytotox
hcq
cell
mtt
assay
result
indic
equit
hcq
dose
use
system
fig
thu
hcqrestrict
replic
due
impair
cell
prolifer
moreov
hcq
inhibit
infect
macrophag
ic
mm
supplementari
fig
mtt
assay
clarifi
dose
hcq
affect
macrophag
viabil
supplementari
fig
consist
result
shown
cell
infect
viral
protein
express
untransl
region
viral
gene
express
virion
product
attenu
hcq
suppl
baf
autophagosomelysosom
fusion
modul
similar
pharmacolog
effect
hcq
rubinsztein
other
found
inhibit
influenza
b
viru
infect
ochiai
other
note
activ
baf
similar
hcq
posit
control
ifna
fig
infect
requir
cellular
activ
autophagosomelysosom
fusion
besid
block
infect
hcq
also
antivir
effect
serotyp
fig
howev
higher
dose
hcq
might
requir
suppress
effici
overal
data
show
hcq
interfer
denv
infect
vitro
address
antivir
mechan
hcq
infect
hcq
ad
cell
viral
adsorpt
fig
upper
panel
ifa
infect
reveal
hcq
pretreat
suppress
infect
wherea
replic
partial
reduc
hcq
ad
viru
adsorpt
cell
pretreat
mm
hcq
mm
bafilomycin
u
type
h
infect
multipl
infect
moi
ifa
infect
antibodi
left
panel
dapi
nuclear
stain
right
panel
quantif
e
cell
pretreat
mm
hcq
h
infect
denv
serotyp
moi
h
green
fluoresc
dapi
blue
floresc
stain
imag
merg
show
denvinfect
cell
quantif
p
p
p
versu
untreat
control
group
viral
adsorpt
ce
fig
infect
greatli
inhibit
cell
incub
hcq
viral
adsorpt
time
f
g
fig
thu
longterm
hcq
treatment
may
better
inhibit
effect
replic
infect
estim
ifa
gave
similar
result
fig
plaqueform
assay
titrat
confirm
hcqmediat
restrict
infect
fig
thu
hcq
pretreat
may
chang
host
cell
physic
condit
trigger
host
defens
system
denv
infect
type
ifn
associ
antivir
protein
play
crucial
role
host
innat
immun
hcq
pretreat
effici
inhibit
infect
investig
whether
hcq
activ
host
defens
machineri
found
high
induct
sever
innat
immun
gene
human
cell
treat
high
dose
hcq
tabl
gene
includ
ifnb
ifninduc
protein
tetratricopeptid
repeat
cxc
motif
chemokin
viperin
mav
tumor
necrosi
factor
receptorassoci
factor
addit
sever
gene
tnf
receptorassoci
factor
rigi
ubiquit
express
transcript
tripartit
motifcontain
protein
major
vault
protein
mvp
detect
hcqtreat
murin
macrophag
tabl
furthermor
mrna
express
inflammatori
cytokin
tnfa
induc
hcq
macrophag
tabl
thu
hcqcontrol
infect
may
associ
activ
host
innat
immun
respons
hcq
induc
antivir
gene
ifnb
viperin
cell
suggest
gene
might
major
effector
induc
hcq
attenu
replic
address
hcq
induc
express
host
defens
gene
measur
abil
hcq
turn
luciferas
report
driven
ifnb
promot
nfkb
bind
site
doli
other
hcq
dosedepend
increas
ifnb
nfkb
report
activ
fig
furthermor
stimul
hcq
induc
phosphoryl
indic
activ
phosphocjun
indic
activ
also
induc
hcq
treatment
hcq
timedepend
activ
nfkb
increas
nfkb
express
degrad
ikba
fig
hcq
significantli
induc
nfkb
transloc
nucleu
pattern
similar
posit
control
polyi
c
stimul
fig
f
thu
report
assay
immunoblot
result
nfkb
nuclear
transloc
analysi
consist
show
hcq
activ
host
antivir
signal
transduct
pathway
mav
play
pivot
role
type
ifn
activ
pathway
kumar
other
mav
one
antivir
gene
induc
hcq
cell
tabl
aim
confirm
whether
mav
involv
hcq
antivir
activ
immunoblot
result
show
increas
mav
protein
express
hcq
fig
consist
mrna
induct
mav
hcq
report
assay
reveal
hcq
enhanc
mavstransactiv
ifnb
isr
nfkb
luciferas
activ
fig
exogen
mav
express
higher
hcqtreat
untreat
control
cell
fig
data
impli
mav
protein
stabil
decreas
hcq
use
sirna
transfect
knock
endogen
mav
express
valid
role
mav
hcqrestrict
immunoblot
confirm
effici
mav
knockdown
fig
mav
knockeddown
neg
control
cell
infect
compar
neg
control
sirnatransfect
cell
mav
knockeddown
cell
hcq
fail
inhibit
infect
fig
estim
data
infect
ifa
viral
titer
show
consist
result
fig
moreov
examin
function
mav
hcq
antivir
effect
previous
establish
cell
carri
shmav
mav
knockdown
shlacz
neg
control
yu
other
rtqpcr
confirm
mav
knockdown
effici
shrna
hcqmediat
mav
mrna
express
inhibit
cell
fig
hcqmediat
nuclear
transloc
nfkb
control
cell
downregul
mav
knockeddown
cell
fig
j
therefor
mav
essenti
hcqstimul
antivir
activ
activ
innat
immun
pathway
clarifi
type
ifn
antivir
system
play
critic
role
denv
inhibit
hcq
block
type
ifn
signal
ifnab
receptor
antagonist
cell
cell
treat
hcq
infect
infect
titrat
data
indic
reduc
effici
hcq
cell
block
type
ifn
signal
fig
hcq
also
inhibit
ademedi
infect
macrophag
block
type
ifn
signal
reduc
hcq
inhibit
effici
fig
mav
downstream
ikb
kinas
ikk
relat
kinas
ikk
phosphoryl
total
rna
harvest
cell
without
hydroxychloroquin
hcq
treatment
mm
h
rtqpcr
mrna
level
normal
intern
control
hypoxanthin
phosphoribosyltransferas
hprt
fold
induct
solvent
control
mean
sd
ifninduc
protein
tetratricopeptid
repeat
ifnb
interferon
beta
cxc
motif
chemokin
melanoma
differentiationassoci
protein
cytomegalovirusinduc
gene
protein
mav
mitochondri
antivir
signal
protein
tnf
receptorassoci
factor
mous
macrophag
treat
mm
hcq
solvent
control
h
rtqpcr
mrna
level
normal
intern
control
hprt
fold
induct
solvent
control
mean
sd
ifnb
interferon
beta
cytomegalovirusinduc
gene
protein
ifninduc
protein
tetratricopeptid
repeat
interferon
regulatori
factor
tnf
receptorassoci
factor
mav
mitochondri
antivir
signal
protein
rigi
retino
acidinduc
gene
protein
melanoma
differentiationassoci
protein
mav
mitochondri
antivir
signal
protein
ubiquit
express
transcriptvari
tripartit
motifcontain
protein
mvp
major
vault
protein
tnfa
tumor
necrosi
factor
alpha
type
ifn
induct
pathway
sharma
other
treatment
ikk
inhibitor
mm
clark
other
amlexanox
mm
reilli
other
attenu
hcq
activ
fig
data
support
hcq
activ
host
type
ifn
antivir
machineri
denv
infect
ro
play
import
role
normal
cell
signal
homeostasi
ro
also
activ
host
defenc
system
exampl
promot
signal
pathway
drive
nfkb
activ
kohchi
other
morgan
liu
proinflammatori
cytokin
product
bulua
other
addit
druginduc
oxid
stress
cell
describ
deaval
other
therefor
investig
whether
ro
contribut
hcqstimul
innat
immun
infect
dcfhda
assay
use
assess
cell
aranda
other
found
ro
signal
dichlorofluorescein
dcf
hcqtreat
cell
fig
confirm
hcq
induc
signific
ro
product
fig
h
stimul
posit
control
fig
b
right
panel
similar
immunoblot
result
hcq
stimul
fig
h
stimul
increas
cellular
mav
phosphoryl
cjun
level
ikb
degrad
fig
ro
involv
innat
immun
signal
pathway
substanti
role
ro
hcq
antivir
effect
use
nonspecif
ro
scaveng
pbn
fidanboylu
other
global
decreas
cellular
ro
level
pbn
significantli
reduc
level
hcqinduc
ro
gener
fig
hcqrestrict
infect
attenu
pbn
fig
along
pbnreduc
hcqmediat
ro
gener
hcqenhanc
express
mav
phosphocjun
downregul
pbntreat
cell
hcqmediat
ikba
degrad
also
inhibit
pbn
fig
importantli
pbn
reduc
rosinhibit
hcq
hcq
mavsstimul
luciferas
report
activ
ifnb
isr
nfkb
fig
data
provid
novel
insight
antivir
activ
hcq
mediat
ro
mav
involv
host
defens
machineri
indic
key
role
ro
drugactiv
host
antivir
innat
immun
studi
valid
hcq
potenti
denv
infect
inhibitor
activ
innat
immun
signal
pathway
nfkb
downstream
gene
hcq
induc
express
antivir
factor
ifnb
viperin
mav
cytokin
tnfa
mav
knockdown
show
essenti
role
mav
hcqinhibit
infect
block
type
ifn
pathway
antiifnab
receptor
antibodi
ikk
inhibitor
reduc
hcq
antidenv
activ
addit
hcqstimul
ro
gener
key
factor
trigger
host
innat
immun
activ
restrict
data
reveal
emerg
role
hcq
activ
host
defenc
machineri
viral
infect
role
ro
inflamm
host
defens
establish
mice
lack
ro
activ
high
suscept
bacteri
infect
shiloh
other
kohchi
other
bulua
other
similar
find
rospromot
host
antivir
machineri
demonstr
studi
herp
simplex
viru
hsv
infect
naturalcompound
stilbenoid
show
antihsv
effect
induc
ro
express
chen
other
ro
might
signal
messeng
hsv
infect
activ
nfkb
pathway
produc
type
ifn
inflammatori
cytokin
gonzalezdos
other
hu
other
sophist
regul
mechan
reveal
ro
directli
induc
posttransl
modif
sglutathionyl
import
activ
innat
immun
pathway
gonzalezdos
other
thu
elucid
whether
hcq
promot
posttransl
modif
signal
protein
regul
innat
immun
respons
would
interest
reveal
ro
critic
hcqactiv
innat
immun
signal
antivir
respons
er
stress
affect
hcq
treatment
hcq
enhanc
express
er
stress
pathway
immunoglobulin
heavi
perk
level
chaperon
protein
er
calnexin
chop
pdi
er
chang
hcq
treatment
along
hcq
dithiothreitol
treatment
posit
control
could
activ
perk
bip
supplementari
fig
nadanaka
other
thu
pathway
er
stress
might
involv
hcqinduc
innat
immun
activ
role
innat
immun
respons
abl
activ
signal
nfkb
via
mapk
pathway
express
gene
associ
host
defens
xu
other
also
activ
er
stress
synergist
tlr
activ
cytokin
product
macrophag
bacteri
infect
martinon
other
understand
role
hcq
infect
would
import
moreov
ro
product
er
stress
activ
show
crosstalk
featur
also
support
find
hcq
malhotra
kaufman
hcq
cq
weak
basic
drug
accumul
acid
environ
cellular
organel
inhibit
replic
differ
virus
interf
endosomelysosom
traffick
viral
protein
matur
virion
matur
exampl
cq
chang
structur
newli
produc
hiv
glycoprotein
savarino
other
block
proteolyt
process
denv
prm
protein
acid
postgolgi
vesicl
randolph
other
also
demonstr
similar
pneumonia
hcq
interrupt
endosomelysosom
pathway
monitor
cellular
express
pattern
transferrin
receptor
tfnr
marker
earlyrecycl
endosom
shin
other
data
show
tfnrassoci
endosom
vesicl
enlarg
accumul
form
punctat
structur
hcqtreat
cell
supplementari
fig
cq
found
suppress
jev
intern
zhu
other
exclud
possibl
hcq
block
entri
howev
requir
investig
hcq
cq
wellknown
autophagi
pathway
inhibitor
rubinsztein
other
doublestrand
rna
stimul
found
switch
cellular
activ
autophagi
innat
immun
respons
activ
simicek
other
suggest
mutual
antagonist
regul
autophagi
innat
immun
ro
activ
might
involv
bactin
intern
load
control
e
mav
control
sirnatransfect
cell
treat
hcq
h
infect
moi
ifa
cell
antibodi
green
color
dapi
stain
nuclei
blue
color
infect
f
plaqu
assay
viral
titrat
g
e
h
rtqpcr
analysi
mav
mrna
express
shlacz
shmav
stabli
express
cell
treat
hcq
mm
h
j
ifa
nuclear
transloc
nfkb
cell
describ
h
right
panel
estim
rate
nfkb
nuclear
transloc
data
mean
sd
least
independ
test
p
p
p
exampl
autophagi
modualt
nacht
lrr
pyd
domaincontain
protein
inflammasom
rosmedi
inflammtori
cytokin
express
nakahira
other
autophagi
also
inhibit
rosmedi
mav
aggreg
downregul
type
ifn
product
zhao
other
autophagi
enhanc
jev
denv
replic
lee
other
heaton
randal
li
other
might
reflect
flavivirus
downregul
innat
antivir
respons
activ
autophagi
pathway
replic
find
may
support
result
nevertheless
detail
role
autophagi
viru
replic
host
defenc
remain
valid
jounai
other
ke
chen
dong
levin
found
hcq
pretreat
induc
express
multipl
antiviralassoci
protein
type
ifn
viperin
rigi
mav
demonstr
suppress
flaviviru
infect
quantif
infect
left
panel
repres
immunofluoresc
imag
right
panel
inhibitor
c
amlexanox
coincub
mm
hcq
indic
cell
cell
infect
moi
h
quantif
infect
left
panel
immunofluoresc
imag
right
panel
shown
data
mean
sd
independ
experi
p
p
fig
hcq
induc
reactiv
oxygen
speci
ro
gener
ro
detect
dcfhda
assay
cell
hcq
treatment
h
dcf
signal
cell
h
treatment
min
posit
control
b
quantif
ro
product
dcf
fluoresc
hcq
left
panel
h
treat
cell
right
panel
data
mean
sd
n
p
p
c
immunoblot
h
treat
cell
indic
antibodi
cell
pretreat
mm
ntertbutyl
phenylnitron
pbn
h
hcq
mm
h
ro
detect
dcfhda
assay
data
mean
sd
n
p
e
left
panel
cell
pretreat
pbn
mm
h
hcq
mm
h
cell
infect
moi
ifa
infect
h
antibodi
green
color
dapi
stain
nuclei
blue
color
estim
infect
right
panel
data
mean
sd
n
p
f
immunoblot
mav
total
protein
level
load
control
bactin
cell
pretreat
pbn
mm
h
hcq
mm
h
g
dual
luciferas
assay
ifnb
nfkb
isr
luciferas
report
cell
cotransfect
luc
report
mg
prltk
mg
plu
empti
vector
mg
treat
pbn
mm
h
hcq
mm
h
data
mean
sd
independ
experi
p
p
signalosom
mitochondria
critic
host
antivir
activ
huang
other
understand
whether
hcq
regul
signalosom
activ
critic
studi
hcq
greatli
inhibit
viral
replic
cell
treat
hcq
infect
thu
cellular
environ
chang
hcq
treatment
may
crucial
restrict
infect
wherea
late
stage
interfer
virion
matur
might
major
mechan
hcq
activ
thu
hcq
prevent
treatment
area
season
dengu
pandem
might
feasibl
strategi
reduc
sever
spread
denv
outbreak
moreov
result
clinic
trial
show
patient
receiv
hcq
combin
antivir
drug
hydroyurea
didanosin
show
significantli
reduc
hiv
viral
load
increas
count
paton
aboulhab
therefor
combin
therapi
hcq
antivir
drug
could
consid
denv
infect
control
exampl
iminosugar
deriv
wu
other
may
use
hcq
prevent
denv
infect
conclus
demonstr
hcq
could
restrict
denv
infect
activ
ro
mavsmedi
host
ifn
antivir
pathway
hcq
market
drug
may
develop
clinic
therapi
denv
infect
work
support
grant
kaohsiung
veteran
gener
hospit
part
zuoy
branch
kaohsiung
arm
forc
gener
hospit
kaohsiung
taiwan
zafgh
funder
role
studi
design
data
collect
analysi
decis
publish
prepar
articl
